Jim Dobbin – 2014 Parliamentary Question to the Attorney General

The below Parliamentary question was asked by Jim Dobbin on 2014-06-09.

To ask the Attorney General, what the terms of reference are for the investigation by the Serious Fraud Office (SFO) into GlaxoSmithKline (GSK); whether the SFO will investigate (a) GSK’s activities within the UK, (b) allegations of bribery of UK doctors, (c) promotion of Seroxat prescribing for children and (d) the 2002 CSM Expert Working Group on the safety of SSRI antidepressants; and whether there is a point of contact for members of the public who wish to help the SFO investigation.

Mr Dominic Grieve

The Director of the Serious Fraud Office (SFO) recently announced that he has opened a criminal investigation into the commercial practices of GlaxoSmithKline plc and its subsidiaries. The SFO investigation will follow the evidence and it is not appropriate to comment whilst enquiries are continuing.

A press release regarding GlaxoSmithKline and information on how to contact the SFO can be found on its website at www.sfo.gov.uk

“